Beasley Allen in the News

Articles 291 to 300 of 649.

Merck Executive Denies pressuring Doctor ver Vioxx

December 7, 2005

A Merck executive denied today she tried to pressure one of the nation's top cardiologists into not publishing an article in a highly respected medical journal raising concerns that Vioxx could cause heart attacks and strokes.

Merck Stresses Concern for Vioxx Users' Safety

NATIONAL PUBLIC RADIO | December 6, 2005

NPR.org, December 6, 2005 – In the first full day of defense testimony at the federal Vioxx trial in Houston, witnesses for drug manufacturer Merck presented the company and its scientists as careful, methodical and, above all, concerned about the safety of the users of its drugs.

Merck Stresses Concern for Vioxx users Safety

December 6, 2005

Witnesses for drug manufacturer Merck presented the company and its scientists as careful, methodical and, above all, concerned about the safety of the users of its drugs.

Doctor testifies even low doses of Vioxx dangerous

THE HOUSTON CHRONICLE | December 2, 2005

A doctor who has analyzed the effects of Vioxx on the heart denied today that four studies that he says showed the link in low-dose use were statistically insignificant.

Doctor Testifies that Merck Studies Showed Vioxx Risks

THE WALL STREET JOURNAL | December 1, 2005

HOUSTON – Many of Merck’s own studies in Vioxx produced data indicating that the painkiller increase risks of hear attacks, even if taken over a short period of time, an epidemiologist testified on behalf of plaintiffs in a federal case here.

In the Courts: Vioxx Judge Allows Testimony from Cleveland Clinic Cardiologist

AMERICAN HEALTH LINE | November 30, 2005

U.S. District Court Judge Eldon Fallon on Tuesday ruled that plaintiff attorneys can present as evidence a videotaped deposition from a Cleveland Clinic Cardiologist who has criticized how Merck handled the market withdrawal of the COX-2 inhibitor Vioxx in the first federal lawsuit related to the me…

Third Merck Trial

November 30, 2005

Merck hid the health risks of Vioxx to protect profit, a lawyer representing the family of a man who died after using the pain reliever for 23 days told jurors yesterday in the first federal trial over the drug.

Battle over Vioxx enters a Crucial New Phase

November 29, 2005

The litigation over injury claims from withdrawn painkiller Vioxx enters a critical new phase today, as manufacturer Merck faces its first trial in federal court.

Merck's Vioxx Showdown in Texas

November 29, 2005

Jury selection began in Houston on Tuesday in the latest high stakes legal battle for Merck & and its first in a federal courtroom.

Merck is likely to Win First Federal Vioxx Lawsuit

November 29, 2005

Merck & Co., with one victory and one loss in Vioxx lawsuits tried in state courts, may win the first federal trial over the painkiller, lawyers said.